Baidu
map

Cell Host & Micro:开发出监视机体感染炎症应答反应的3D成像技术

2012-08-14 T.Shen 生物谷

近日,来自范德堡大学的研究者指出,一种揭示人体针对感染产生的免疫效应和识别涉及免疫反应蛋白质的3D成像技术可以为未来感染性疾病提供新的标志物和新型的药物开发思路。研究者结合了磁共振成像(MRI)和质谱成像技术来显现小鼠对于细菌感染所产生的炎症免疫反应。相关研究结果刊登在了国际杂志Cell Host & Microbe上。 研究者Skaar和其同事非常感兴趣在动物感染中的三维成像感染技术,

近日,来自范德堡大学的研究者指出,一种揭示人体针对感染产生的免疫效应和识别涉及免疫反应蛋白质的3D成像技术可以为未来感染性疾病提供新的标志物和新型的药物开发思路。研究者结合了磁共振成像(MRI)和质谱成像技术来显现小鼠对于细菌感染所产生的炎症免疫反应。相关研究结果刊登在了国际杂志Cell Host & Microbe上。

研究者Skaar和其同事非常感兴趣在动物感染中的三维成像感染技术,通过这种技术,研究者可以是发现在特异的感染部位所产生的蛋白质,MRI技术就提供了组织损伤的解剖学影像技术。质谱成像技术可以直接测定组织中的蛋白质、脂质和其它代谢产物。

这项新型技术允许研究者观察到感染动物的单一图像,并且可以观察到免疫系统的蛋白如何做出反应以及感染的组织如何被定位。研究者希望研究这些蛋白质来开发出针对感染的新的标志物,这将会有效改善诊断学工具或者新的治疗干预靶点。

这项技术对于科学家们研究感染性疾病、癌症以及自体免疫疾病的炎症反应非常重要。尽管这种技术是非侵袭性的,其只适用于移除的病人组织。相关研究由国立卫生研究院提供支持。

编译自:New View of Body's Infection Response

doi:10.1016/j.chom.2012.04.018
PMC:
PMID:

Monitoring the Inflammatory Response to Infection through the Integration of MALDI IMS and MRI

Ahmed S. Attia, Kaitlin A. Schroeder, Erin H. Seeley, Kevin J. Wilson, Neal D. Hammer, Daniel C. Colvin, M. Lisa Manier, Joshua J. Nicklay, Kristie L. Rose, John C. Gore, Richard M. Caprioli, Eric P. Skaar

Systemic bacterial infection is characterized by a robust whole-organism inflammatory response. Analysis of the immune response to infection involves technologies that typically focus on single organ systems and lack spatial information. Additionally, the analysis of individual inflammatory proteins requires antibodies specific to the protein of interest, limiting the panel of proteins that can be analyzed. Herein we describe the application of matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI IMS) to mice systemically infected with Staphylococcus aureus to identify inflammatory protein masses that respond to infection throughout an entire infected animal. Integrating the resolution afforded by magnetic resonance imaging (MRI) with the sensitivity of MALDI IMS provides three-dimensional spatially resolved information regarding the distribution of innate immune proteins during systemic infection, allowing comparisons to in vivo structural information and soft-tissue contrast via MRI. Thus, integrating MALDI IMS with MRI provides a systems-biology approach to study inflammation during infection.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2084080, encodeId=50872084080b5, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Thu Jul 11 16:08:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857296, encodeId=7932185e29676, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sat Nov 24 08:08:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958816, encodeId=caba19588160b, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Dec 26 11:08:00 CST 2012, time=2012-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868583, encodeId=a9c11868583b4, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Feb 12 00:08:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335803, encodeId=d3f7133580373, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570720, encodeId=ac5e15e072009, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=)]
    2013-07-11 xjy02
  2. [GetPortalCommentsPageByObjectIdResponse(id=2084080, encodeId=50872084080b5, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Thu Jul 11 16:08:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857296, encodeId=7932185e29676, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sat Nov 24 08:08:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958816, encodeId=caba19588160b, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Dec 26 11:08:00 CST 2012, time=2012-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868583, encodeId=a9c11868583b4, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Feb 12 00:08:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335803, encodeId=d3f7133580373, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570720, encodeId=ac5e15e072009, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2084080, encodeId=50872084080b5, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Thu Jul 11 16:08:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857296, encodeId=7932185e29676, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sat Nov 24 08:08:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958816, encodeId=caba19588160b, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Dec 26 11:08:00 CST 2012, time=2012-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868583, encodeId=a9c11868583b4, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Feb 12 00:08:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335803, encodeId=d3f7133580373, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570720, encodeId=ac5e15e072009, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=)]
    2012-12-26 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=2084080, encodeId=50872084080b5, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Thu Jul 11 16:08:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857296, encodeId=7932185e29676, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sat Nov 24 08:08:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958816, encodeId=caba19588160b, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Dec 26 11:08:00 CST 2012, time=2012-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868583, encodeId=a9c11868583b4, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Feb 12 00:08:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335803, encodeId=d3f7133580373, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570720, encodeId=ac5e15e072009, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2084080, encodeId=50872084080b5, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Thu Jul 11 16:08:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857296, encodeId=7932185e29676, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sat Nov 24 08:08:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958816, encodeId=caba19588160b, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Dec 26 11:08:00 CST 2012, time=2012-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868583, encodeId=a9c11868583b4, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Feb 12 00:08:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335803, encodeId=d3f7133580373, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570720, encodeId=ac5e15e072009, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2084080, encodeId=50872084080b5, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Thu Jul 11 16:08:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857296, encodeId=7932185e29676, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sat Nov 24 08:08:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958816, encodeId=caba19588160b, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Dec 26 11:08:00 CST 2012, time=2012-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868583, encodeId=a9c11868583b4, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Feb 12 00:08:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335803, encodeId=d3f7133580373, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570720, encodeId=ac5e15e072009, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Aug 16 01:08:00 CST 2012, time=2012-08-16, status=1, ipAttribution=)]

相关资讯

PLoS ONE:间充质干细胞保护移植的胰岛免受炎症作用

近日,来自加拿大阿尔伯塔大学的研究人员发现,人间充质干细胞(MSCs)能够保护胰岛免受促炎性细胞因子的损害,因此在胰岛移植中可能扮演了重要的保护作用。相关研究成果于5月30日在线发表在PLoS ONE上。 1型糖尿病患者为了维持身体健康每天都需要注射胰岛素,则一劳永逸的胰岛移植是一个不错的选择。然而,大多数胰岛移植受体在五年内都失去了胰岛的正常功能。研究发现,炎症是移植失败一个主要的促进因素,而

Cell:革兰氏阴性菌诱发炎症反应机制新解

7月20日,Cell杂志在线报道,革兰氏阴性菌感染通过TRIF信号途径激活NLRP3炎症小体,诱导炎症反应。 由于可引发"败血症综合征",一种全身性难以控制的炎症反应,革兰氏阴性菌全身性感染以高死亡率著称。虽然大家公认革兰氏阴性细菌感染的免疫反应始于Toll样受体4对内毒素的识别,但革兰氏阴性菌血症过程中发生的炎症反应的分子机制仍不清楚。 本研究揭示了一个TRIF(含TIR结构域的诱导β-干扰

炎症反应或致糖尿病认知功能障碍

  最近,南通大学附属第二医院神经内科、南通大学附属第二医院内分泌科的研究人员的一项研究显示,血清白介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平升高是2型糖尿病患者认知功能下降的一个重要危险因素,提示炎症反应可能参与了糖尿病认知功能障碍的发病。该研究发表于2012年第1期《脑与神经疾病杂志》。   该研究旨在探讨2型糖尿病(DM)患者认知功能障碍与血清IL-6、TNF-α 

Nat Immunol:一种新的炎性蛋白NLRC3显著性影响炎症

北卡罗来纳大学研究人员领导的一个科学家小组在一项新研究中描述了一种之前不了解的蛋白的功能:它能够显著性地影响炎症。 NLR蛋白家族中的大多数成员起着炎症促进物的作用。然而,研究人员报道,一种新鉴定出的NLR蛋白,即NLRC3,能够抑制一种由蛋白NF-Kappa B控制的主要炎性通路。NF-Kappa B激活长期以来就与炎症和促进癌症产生相关联。2012年8月5日,他们的研究论文在线发表在Natu

ATV:高平进等血管外膜介导炎症反应的研究获进展

近日,国际学术期刊《Arteriosclerosis, Thrombosis, and Vascular Biology》在线发表了中国科学院上海生命科学研究院/上海交通大学医学院健康科学研究所和瑞金医院上海市高血压研究所高平进课题组最新研究成果:“VEGF-induced Osteopontin Expression Mediates Vascular Inflammation and Neoi

Biochem J:新方法防止糖尿病眼疾视网膜受损

近日,密歇根大学凯洛格眼科中心研究人员发现了一种化合物,可以中断糖尿病视网膜病变的视网膜造成损害的事件链。这一发现具有重大意义,因为它可能会导致出现一种新的能根治疾病的治疗方法,该化合物主要作用于两种机制:炎症和削弱保护视网膜的血液屏障。这一化合物通过针对关键蛋白质阻断糖尿病视网膜病变的血管渗漏有关的两个重要途径。 到目前为止,糖尿病性视网膜病变已经为工作年龄段美国人失明的首要原因。在糖尿病性视

Baidu
map
Baidu
map
Baidu
map